Bromide

Bromide

SCHEMBL4542897

Br.c1ccc(CNCc2ccc(CNC3CCCc4ccccc43)cc2)nc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 4/20 0.51
PRMT5 O14744 1/20 0.47
CXCR4 P61073 5/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
HDAC1 Q13547 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HRH3 Q9Y5N1 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1870578 0.99 KDM4E (0.53) KDM4EALDH1A1PRMT5CXCR4CYP3A4
SCHEMBL29823129 0.99 KDM4E (0.53) KDM4EALDH1A1PRMT5CXCR4CYP3A4
Bromide SCHEMBL4543315 0.88 HDAC1 (0.61) KDM4EALDH1A1CXCR4CYP3A4CYP2D6
Bromide SCHEMBL4543066 0.88 L3MBTL1 (0.42) KDM4EALDH1A1CXCR4CYP3A4CYP2D6
SCHEMBL29823139 0.86 HDAC1 (0.62) KDM4EALDH1A1CXCR4CYP3A4CYP2D6
SCHEMBL1882612 0.86 HDAC1 (0.62) KDM4EALDH1A1CXCR4CYP3A4CYP2D6
SCHEMBL29823635 0.86 L3MBTL1 (0.43) KDM4EALDH1A1CXCR4CYP3A4CYP2D6
SCHEMBL1880250 0.86 L3MBTL1 (0.43) KDM4EALDH1A1CXCR4CYP3A4CYP2D6
Bromide SCHEMBL4550638 0.85 HDAC1 (0.58) ALDH1A1CXCR4CYP3A4CYP2D6HDAC1
SCHEMBL30338473 0.84 KDM4E (0.51) KDM4EALDH1A1PRMT5CXCR4CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629337-B2 Chemokine receptor binding heterocyclic compounds GENZYME CORPORATION (US) 2009-12-08 US disclosed
US-20060264434-A1 Chemokine receptor binding heterocyclic compounds ANORMED INC. (CA) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264434-A1 Chemokine receptor binding heterocyclic compounds CCR5, CXCR4, CXCR1 KDM4E 4279/4885ALDH1A1 1458/4885PRMT5 1621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.